StimOxyGen Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.9M

  • Investors
  • 6

StimOxyGen General Information

Description

Developer of stimulus-responsive therapeutic systems designed for the treatment of cancer. The company's system offers a nanoparticle formulation that dissolves at a low hydrogen potential and transiently generates oxygen in hypoxic tumors, enabling doctors to meet clinical needs by fueling tumors with oxygen to maximize the therapeutic effects of radiotherapy.

Contact Information

Website
www.stimoxygen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • School of Pharmacy and Pharmaceutical Sciences
  • Cromore Road, Coleraine Co. Derry
  • Londonderry BT52 1SA
  • Northern Ireland, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, Life Sciences, Oncology
Corporate Office
  • School of Pharmacy and Pharmaceutical Sciences
  • Cromore Road, Coleraine Co. Derry
  • Londonderry BT52 1SA
  • Northern Ireland, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StimOxyGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 11-Mar-2025 $1.9M Completed Pre-Clinical Trials
3. Grant 01-Oct-2021 Completed Pre-Clinical Trials
2. Accelerator/Incubator $660K $660K Completed Startup
1. University Spin-Out 09-Mar-2021 Completed Startup
To view StimOxyGen’s complete valuation and funding history, request access »

StimOxyGen Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

StimOxyGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3618874-A2 Therapy Pending 04-May-2017

StimOxyGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StimOxyGen Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clarendon Fund Managers Venture Capital Minority
DSW Ventures Venture Capital Minority
QUBIS Venture Capital Minority
Catalyst (EU) Not-For-Profit Venture Capital
Duncreggan Student Village University
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

StimOxyGen FAQs

  • When was StimOxyGen founded?

    StimOxyGen was founded in 2021.

  • Where is StimOxyGen headquartered?

    StimOxyGen is headquartered in Londonderry, United Kingdom.

  • What is the size of StimOxyGen?

    StimOxyGen has 5 total employees.

  • What industry is StimOxyGen in?

    StimOxyGen’s primary industry is Drug Discovery.

  • Is StimOxyGen a private or public company?

    StimOxyGen is a Private company.

  • What is StimOxyGen’s current revenue?

    The current revenue for StimOxyGen is .

  • How much funding has StimOxyGen raised over time?

    StimOxyGen has raised $2.56M.

  • Who are StimOxyGen’s investors?

    Clarendon Fund Managers, DSW Ventures, QUBIS, Catalyst (EU), and Duncreggan Student Village are 5 of 6 investors who have invested in StimOxyGen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process